PRCT

PROCEPT BioRobotics Corp

Nasdaq · Surgical & Medical Instruments & Apparatus · Inc. DE · CIK 0001588978
$25.70 -7.17% $1.5B
Insider Selling Cluster (3 insiders)High Impact Filing (7/10)16 New Institutional Positions9 Institutional Exits
Vol
Market Cap$1.5B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (71%)
Inst. Holders50 funds
Inst. Value$788.3M
Inst. Activity16 buys / 9 sells
Insider Activity3B / 9S
Insider Net $$6.6M
SEC Reports10
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001588978·Prev Close $27.69

Recent Activity

Jun 11, 2026 SEC
A mixed institutional cluster for PROCEPT BioRobotics in Q3 2025 shows three buyers (including Citadel doubling and UBS
INST-CLUSTER — Impact 4/10
Jun 10, 2026 SEC
Three EVP-level insiders (CFO, CLO, CTO) at PROCEPT BioRobotics sold small open-market positions on June 8, 2026, totali
CLUSTER — Impact 2/10
Jun 10, 2026 SEC
Three PROCEPT executives (CFO, CTO, CLO) sold a combined ~1,000 shares worth ~$28K in open-market transactions on June 8
CLUSTER — Impact 2/10
Jun 9, 2026 Insider
PUCKETT DAN was granted 3,315 shares
Director
Jun 9, 2026 Insider
PUCKETT DAN was granted 5,853 shares
Director
Jun 9, 2026 Insider
PRESCOTT THOMAS M was granted 5,853 shares
Director
Inst.
FMR LLC — TRIM
1,461,904 shares ($36.6M)
Inst.
Point72 Asset Management, L.P. — NEW
1,128,543 shares ($28.2M)

Price Targets

$30.22 +17.6% upside Buy
Current $25.71 Low $20.00 Median $30.00 High $37.00 9 analysts
$20.00 $37.00

Analyst Ratings

Buy71% buy · 21 analysts
5Strong Buy
10Buy
5Hold
1Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
Jun 11, 2026 Leerink Partners DOWNGRADE Outperform → Market Perform
Apr 30, 2026 Piper Sandler REITERATE Overweight → Overweight
Mar 6, 2026 Baird INITIATE Neutral
Mar 2, 2026 Truist Securities MAINTAIN Buy → Buy
Feb 26, 2026 Leerink Partners MAINTAIN Outperform → Outperform

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.46 ▼ -0.6% $-0.49 — $-0.36 -30% YoY 10
Next Q $-0.34 ▲ +0.5% $-0.40 — $-0.30 12% YoY 10
Current FY $-1.51 ▲ +0.5% $-1.61 — $-1.43 12% YoY 10
Next FY $-0.87 ▲ +1.8% $-1.23 — $-0.56 43% YoY 10

Latest Reports

MIXED INST-CLUSTER 4/10
A mixed institutional cluster for PROCEPT BioRobotics in Q3 2025 shows three buyers (including Citadel doubling and UBS
Jun 11, 2026
NEUTRAL CLUSTER 2/10
Three EVP-level insiders (CFO, CLO, CTO) at PROCEPT BioRobotics sold small open-market positions on June 8, 2026, totali
Jun 10, 2026

Top Institutional Holders

FundValueMove
BlackRock, Inc.$109.1M—
BNP Paribas Asset Management$77.3MDOUBLED
VANGUARD PORTFOLIO MANAGEMENT LLC$60.6M—
VANGUARD CAPITAL MANAGEMENT LLC$60.0M—
MACKENZIE FINANCIAL CORP$43.0M—

Recent Insider Trades

DateInsiderTypeValue
Jun 9, 2026PUCKETT DANA$0.00
Jun 9, 2026PUCKETT DANA$0.00
Jun 9, 2026PRESCOTT THOMASA$0.00
Jun 9, 2026PRESCOTT THOMASA$0.00
Jun 9, 2026MOLL FREDERICA$0.00
50 institutional holders with $788.3M total value (31,479,119 shares) as of 2026-Q1. Top holders: BlackRock,, BNP, VANGUARD. Net buying activity: 16 institutions added/increased vs 9 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1BlackRock, Inc.4,362,002$109.1M13.8%—
2BNP Paribas Asset Management Holding S.A.3,089,378$77.3M9.8%DOUBLED +183.3%
3VANGUARD PORTFOLIO MANAGEMENT LLC2,421,362$60.6M7.7%—
4VANGUARD CAPITAL MANAGEMENT LLC2,399,067$60.0M7.6%—
5MACKENZIE FINANCIAL CORP1,720,738$43.0M5.5%—
6STATE STREET CORP1,529,631$38.3M4.9%—
7FMR LLC1,461,904$36.6M4.6%TRIM -68.6%
8Artisan Partners Limited Partnership1,187,349$29.7M3.8%—
9Point72 Asset Management, L.P.1,128,543$28.2M3.6%NEW
10MORGAN STANLEY977,407$24.4M3.1%—
11BAILLIE GIFFORD & CO973,502$24.3M3.1%—
12WELLINGTON MANAGEMENT GROUP LLP861,605$21.5M2.7%NEW
13MARSHALL WACE, LLP698,232$17.5M2.2%DOUBLED +221.1%
14BANK OF AMERICA CORP /DE/630,689$15.8M2.0%ADD +46.3%
15FRONTIER CAPITAL MANAGEMENT CO LLC609,857$15.3M1.9%DOUBLED +160.4%
16MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.481,300$12.0M1.5%TRIM -31.2%
17CHARLES SCHWAB INVESTMENT MANAGEMENT INC457,056$11.4M1.5%—
18WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC424,309$10.6M1.3%—
19VANGUARD FIDUCIARY TRUST CO384,311$9.6M1.2%—
20JANUS HENDERSON GROUP PLC384,246$9.6M1.2%DOUBLED +1222.3%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
FMR LLCTRIM4,653,1111,461,904-68.6%$36.6M2026-Q1
Point72 Asset Management, L.P.NEW—1,128,543—$28.2M2026-Q1
WELLINGTON MANAGEMENT GROUP LLPNEW—861,605—$21.5M2026-Q1
MARSHALL WACE, LLPDOUBLED217,442698,232+221.1%$17.5M2026-Q1
BANK OF AMERICA CORP /DE/ADD431,205630,689+46.3%$15.8M2026-Q1
FRONTIER CAPITAL MANAGEMENT CO LLCDOUBLED234,180609,857+160.4%$15.3M2026-Q1
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.TRIM699,971481,300-31.2%$12.0M2026-Q1
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ADD263,227377,600+43.5%$9.4M2026-Q1
Trexquant Investment LPDOUBLED147,988373,400+152.3%$9.3M2026-Q1
BLAIR WILLIAM & CO/ILADD210,266323,935+54.1%$8.1M2026-Q1
Nuveen, LLCTRIM282,282197,766-29.9%$4.9M2026-Q1
ENVESTNET ASSET MANAGEMENT INCADD88,063139,070+57.9%$3.5M2026-Q1
STATE OF WISCONSIN INVESTMENT BOARDADD83,719131,235+56.8%$3.3M2026-Q1
Brevan Howard Capital Management LPADD27,88248,239+73.0%$1.2M2026-Q1
DnB Asset Management ASTRIM99,56747,151-52.6%$1.2M2026-Q1
ASSETMARK, INCDOUBLED7,91024,118+204.9%$603.2K2026-Q1
STIFEL FINANCIAL CORPADD15,07220,514+36.1%$513.0K2026-Q1
CWM, LLCDOUBLED1,41511,595+719.4%$290.0K2026-Q1
Mirae Asset Global Investments Co., Ltd.TRIM10,5197,621-27.6%$190.6K2026-Q1
NISA INVESTMENT ADVISORS, LLCDOUBLED301,243+4043.3%$31.1K2026-Q1
Allworth Financial LPDOUBLED133793+496.2%$19.8K2026-Q1
LOS ANGELES CAPITAL MANAGEMENT LLCNEAR_EXIT5,956284-95.2%$7.1K2026-Q1
PNC FINANCIAL SERVICES GROUP, INC.NEAR_EXIT4,739124-97.4%$3.1K2026-Q1
HRT FINANCIAL LPTRIM69,87225,726-63.2%$643.002026-Q1
ADAGE CAPITAL PARTNERS GP, L.L.C.EXIT389,2780-100.0%$0.002026-Q1
12 unique insiders with 38 transactions. Net insider value: $6.6M ($7.2M bought, $537.1K sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 9, 2026PUCKETT DANDirectorAWARD3,315——
Jun 9, 2026PUCKETT DANDirectorAWARD5,853——
Jun 9, 2026PRESCOTT THOMAS MDirectorAWARD5,853——
Jun 9, 2026PRESCOTT THOMAS MDirectorAWARD3,315——
Jun 9, 2026MOLL FREDERIC HDirectorAWARD3,315——
Jun 9, 2026MOLL FREDERIC HDirectorAWARD5,853——
Jun 9, 2026Little Elisabeth SandovalDirectorAWARD3,315——
Jun 9, 2026Little Elisabeth SandovalDirectorAWARD5,853——
Jun 9, 2026Harris Taylor C.DirectorAWARD3,315——
Jun 9, 2026Harris Taylor C.DirectorAWARD5,853——
Jun 9, 2026Dodrill Amy M.DirectorAWARD3,315——
Jun 9, 2026Dodrill Amy M.DirectorAWARD5,853——
Jun 9, 2026Garrett MaryDirectorAWARD3,315——
Jun 9, 2026Garrett MaryDirectorAWARD5,853——
Jun 9, 2026Desai Antal RohitDirectorAWARD3,315——
Jun 9, 2026Desai Antal RohitDirectorAWARD5,853——
Jun 8, 2026Templin Barry LEVP, Chief Technology OfficerSELL358$28.48$10.2K
Jun 8, 2026Waters KevinEVP, CFOSELL357$28.48$10.2K
Jun 8, 2026Nouri AlalehEVP, CLO, CORP. SEC.SELL285$28.48$8.1K
Mar 19, 2026Nouri AlalehEVP, CLO, CORP. SEC.SELL3,031$25.82$78.3K
Mar 17, 2026Nouri AlalehEVP, CLO, CORP. SEC.SELL304$28.15$8.6K
Mar 17, 2026Waters KevinEVP, CFOSELL706$28.15$19.9K
Mar 10, 2026Nouri AlalehEVP, CLO, CORP. SEC.SELL3,098$25.60$79.3K
Mar 9, 2026Desai Antal RohitDirectorBUY43,581$24.08$1.0M
Mar 6, 2026Nouri AlalehEVP, CLO, CORP. SEC.SELL6,892$23.70$163.4K
Mar 6, 2026Desai Antal RohitDirectorBUY106,554$23.33$2.5M
Mar 6, 2026Waters KevinEVP, CFOSELL6,721$23.70$159.3K
Mar 5, 2026Nouri AlalehEVP, CLO, CORP. SEC.AWARD29,615——
Mar 5, 2026PUCKETT DANDirectorAWARD5,476——
Mar 5, 2026PUCKETT DANDirectorAWARD8,897——
Mar 5, 2026Waters KevinEVP, CFOAWARD47,462——
Mar 5, 2026Waters KevinEVP, CFOAWARD32,576——
Mar 5, 2026Nouri AlalehEVP, CLO, CORP. SEC.AWARD43,811——
Mar 5, 2026Wood Larry LPresident, CEOAWARD127,783——
Mar 5, 2026Wood Larry LPresident, CEOAWARD103,653——
Mar 5, 2026Desai Antal RohitDirectorBUY142,498$25.44$3.6M
Feb 19, 2026Waters KevinEVP, CFOAWARD3,532——
Feb 19, 2026Nouri AlalehEVP, CLO, CORP. SEC.AWARD4,872——
10 SEC filing reports analyzed. Sentiment: 4 bullish, 0 bearish, 1 mixed, 5 neutral. Avg impact: 4.5/10.
MIXED INST-CLUSTER 4/10
A mixed institutional cluster for PROCEPT BioRobotics in Q3 2025 shows three buyers (including Citad
Jun 11, 2026
NEUTRAL CLUSTER 2/10
Three EVP-level insiders (CFO, CLO, CTO) at PROCEPT BioRobotics sold small open-market positions on
Jun 10, 2026
NEUTRAL CLUSTER 2/10
Three PROCEPT executives (CFO, CTO, CLO) sold a combined ~1,000 shares worth ~$28K in open-market tr
Jun 10, 2026
NEUTRAL CLUSTER 2/10
Three EVP-level insiders at PROCEPT BioRobotics Corp sold a total of $28K worth of shares on June 8,
Jun 10, 2026
NEUTRAL CLUSTER 2/10
EVP and CFO Kevin Waters sold $19,876 worth of PRCT shares in a single open-market transaction. The
Mar 19, 2026
BULLISH CLUSTER 7/10
Over the past week, two executives at PROCEPT BioRobotics sold shares totaling approximately $323,00
Mar 12, 2026
BULLISH CLUSTER 7/10
A significant insider trading cluster at PRCT shows substantial open-market buying by director Desai
Mar 9, 2026
NEUTRAL 8-K 3/10
Procept BioRobotics appointed Daniel Puckett to its board of directors and audit committee, effectiv
Mar 6, 2026
BULLISH 8-K 8/10
PROCEPT BioRobotics disclosed its 2026 Analyst Day presentation, highlighting strong financial guida
Feb 26, 2026
BULLISH 8-K 8/10
PROCEPT BioRobotics reported Q4 2025 revenue of $76.4 million, up 12% year-over-year, driven by stro
Feb 25, 2026
∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Buy (71% buy). Based on 21 analysts: 5 strong buy, 10 buy, 5 hold, 1 sell, 0 strong sell.

Analyst Price Targets

$30.22 mean target +17.6% upside Buy (2.17)
$20.00 Low $37.00 High
MetricValue
Current Price$25.71
Target Low$20.00
Target Mean$30.22
Target Median$30.00
Target High$37.00
# Analysts9
RecommendationBuy (2.17)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
 $-0.46 $-0.49 $-0.36 -30.3% -0.6% 0↑ 2↓ $0.1B 17.6% 10
Next Q
2026-09-30
 $-0.34 $-0.40 $-0.30 11.6% +0.5% 1↑ 1↓ $0.1B 23.9% 10
Current FY
2026-12-31
 $-1.51 $-1.61 $-1.43 11.9% +0.5% 1↑ 1↓ $0.4B 29.5% 10
Next FY
2027-12-31
 $-0.87 $-1.23 $-0.56 42.8% +1.8% 1↑ 1↓ $0.5B 23.2% 10

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.456
7d ago$-0.456
30d ago$-0.453-0.003
60d ago$-0.408-0.048
90d ago$-0.403-0.053
8 analyst firms have rated this stock: 0 upgrades, 3 downgrades, 1 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jun 11, 2026 Leerink Partners DOWNGRADE Outperform Market Perform
Apr 30, 2026 Piper Sandler REITERATE Overweight Overweight
Mar 6, 2026 Baird INITIATE — Neutral
Mar 2, 2026 Truist Securities MAINTAIN Buy Buy
Feb 26, 2026 Leerink Partners MAINTAIN Outperform Outperform
Feb 26, 2026 TD Cowen MAINTAIN Buy Buy
Feb 26, 2026 Oppenheimer DOWNGRADE Outperform Perform
Feb 26, 2026 Piper Sandler MAINTAIN Overweight Overweight
Feb 26, 2026 Wells Fargo MAINTAIN Overweight Overweight
Feb 26, 2026 B of A Securities DOWNGRADE Neutral Underperform
Dec 18, 2025 Truist Securities MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 202651051071%
May 1, 202651051071%
Apr 1, 202651051071%
Mar 1, 202651041075%
Feb 1, 202661040080%
Jan 1, 202661040080%
Strong BuyBuyHoldSellStrong Sell
∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 11, 2026
short_volume
Short Volume: PRCT — 71.8% short (0.8M / 1.1M)
Short: 765,764 | Exempt: 6,104 | TRF Vol: 1,067,255 | Short Ratio: 71.8% | Off-exchange volume (dark pool + OTC)
Jun 8, 2026
short_volume
Short Volume: PRCT — 68.4% short (0.4M / 0.6M)
Short: 387,740 | Exempt: 1 | TRF Vol: 567,279 | Short Ratio: 68.4% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: PRCT — 59.1% short (0.4M / 0.6M)
Short: 350,518 | Exempt: 215 | TRF Vol: 592,634 | Short Ratio: 59.1% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: PRCT — 72.8% short (0.4M / 0.5M)
Short: 376,465 | Exempt: 1 | TRF Vol: 517,373 | Short Ratio: 72.8% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: PRCT — 57.7% short (0.7M / 1.2M)
Short: 689,171 | Exempt: 288 | TRF Vol: 1,194,320 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_volume
Short Volume: PRCT — 62.6% short (0.8M / 1.3M)
Short: 818,067 | Exempt: 0 | TRF Vol: 1,305,799 | Short Ratio: 62.6% | Off-exchange volume (dark pool + OTC)
May 8, 2026
short_interest
FTD: PRCT — 22,969 shares ($0.6M) failed to deliver
Settlement: 20260508, Price: $25.44, FTD Value: $584,331.36, PROCEPT BIOROBOTICS CORP COM
May 5, 2026
short_interest
FTD: PRCT — 24,217 shares ($0.6M) failed to deliver
Settlement: 20260505, Price: $24.83, FTD Value: $601,308.11, PROCEPT BIOROBOTICS CORP COM
May 4, 2026
short_interest
FTD: PRCT — 21,387 shares ($0.5M) failed to deliver
Settlement: 20260504, Price: $24.63, FTD Value: $526,761.81, PROCEPT BIOROBOTICS CORP COM
May 4, 2026
short_volume
Short Volume: PRCT — 69.2% short (0.4M / 0.6M)
Short: 414,137 | Exempt: 60 | TRF Vol: 598,153 | Short Ratio: 69.2% | Off-exchange volume (dark pool + OTC)
May 1, 2026
short_volume
Short Volume: PRCT — 56.9% short (0.3M / 0.5M)
Short: 285,121 | Exempt: 5 | TRF Vol: 500,856 | Short Ratio: 56.9% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
short_volume
Short Volume: PRCT — 83.2% short (1.6M / 1.9M)
Short: 1,569,154 | Exempt: 0 | TRF Vol: 1,884,892 | Short Ratio: 83.2% | Off-exchange volume (dark pool + OTC)
Apr 29, 2026
earnings_calendar
PRCT Q1 2026 Earnings After Market Close — 2026-04-29
Apr 29, 2026
short_volume
Short Volume: PRCT — 71.4% short (0.7M / 0.9M)
Short: 671,434 | Exempt: 0 | TRF Vol: 940,095 | Short Ratio: 71.4% | Off-exchange volume (dark pool + OTC)
Apr 9, 2026
earnings
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
<p align="left">SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=8Ny1sqVGze7CAed1PfBMyy8e2pg